Determinants of Idiosyncratic Volatility for Biotech IPO Firms

Jay Inghwee Chok,Qian Sun
2007-01-01
Financial Management
Abstract:In this paper we examine the cross-sectional determinants of idiosyncratic volatility of biotech 1PO firms. We extend current research in two directions. First, we test whether CEO stock options impact idiosyncratic volatility. Second, we test new hypotheses that relate some easily identifiable managerial characteristics to idiosyncratic volatility. We find that the CEO stock options, resource dependence capabilities, and the age of board members help predict idiosyncratic volatility. Our results are robust for the various measures of idiosyncratic volatility and model specifications.
What problem does this paper attempt to address?